Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000899243-18-020534
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-24 19:19:16
Reporting Period:
2018-07-23
Accepted Time:
2018-07-24 19:19:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434418 Constellation Pharmaceuticals Inc CNST () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1180428 J Mark Levin C/o Third Rock Ventures, Llc
29 Newbury Street, 3Rd Floor
Boston MA 02116
No No Yes No
1192603 P Kevin Starr C/o Third Rock Ventures, Llc
29 Newbury Street, 3Rd Floor
Boston MA 02116
No No Yes No
1408591 Third Rock Ventures Lp 29 Newbury Street, 3Rd Floor
Boston MA 02116
No No Yes No
1578973 Trv Gp, Llc 29 Newbury Street, 3Rd Floor
Boston MA 02116
No No Yes No
1578976 Third Rock Ventures Gp, L.p. 29 Newbury Street, 3Rd Floor
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-23 2,705,334 $0.00 2,716,384 No 4 C Direct
Common Stock Acquisiton 2018-07-23 266,667 $15.00 2,983,051 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2018-07-23 11,000,000 $0.00 999,180 $0.00
Common Stock Series B Preferred Stock Disposition 2018-07-23 10,650,000 $0.00 967,389 $0.00
Common Stock Series D Preferred Stock Disposition 2018-07-23 1,086,411 $0.00 98,683 $0.00
Common Stock Series E Preferred Stock Disposition 2018-07-23 2,285,640 $0.00 266,934 $0.00
Common Stock Series E-1 Preferred Stock Disposition 2018-07-23 3,107,930 $0.00 282,308 $0.00
Common Stock Series F Preferred Stock Disposition 2018-07-23 1,000,000 $0.00 90,840 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.
  2. These securities are directly held by Third Rock Ventures, L.P. ("TRV"). The general partner of TRV is Third Rock Ventures GP, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares